TAK-137

DRUG2 trials

Sponsors

Takeda

Conditions

Attention-Deficit/Hyperactivity DisorderDose Finding Study

Phase 1

Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.

TerminatedNCT02163915

TakedaAttention-Deficit/Hyperactivity Disorder

Start: 2014-06-30End: 2014-11-30Updated: 2016-07-11

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-137 in Healthy Participants

CompletedNCT02334982

TakedaDose Finding Study

Start: 2013-06-30End: 2014-01-31Updated: 2015-02-10